融资的机会来了!~多家知名VC公司寻找优质投资标的,感兴趣的管线包括:(1)针对实体瘤的创新性TCE、(2)新靶点/新核素的创新性核药、(3)Abeta双靶点等CNS创新药、(4)新靶点/新MOA的自免创新药。请有相关产品的biotech公司立即联系药时代BD团队(BD@drugtimes.cn)!正文共:1800字预计阅读时间:6分钟截止2025年9月15日收盘,药捷安康-B的港股股价一度飙升至...
Source Link融资的机会来了!~多家知名VC公司寻找优质投资标的,感兴趣的管线包括:(1)针对实体瘤的创新性TCE、(2)新靶点/新核素的创新性核药、(3)Abeta双靶点等CNS创新药、(4)新靶点/新MOA的自免创新药。请有相关产品的biotech公司立即联系药时代BD团队(BD@drugtimes.cn)!正文共:1800字预计阅读时间:6分钟截止2025年9月15日收盘,药捷安康-B的港股股价一度飙升至...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.